Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$3.81 - $6.76 $216,019 - $383,278
-56,698 Reduced 65.11%
30,386 $125,000
Q4 2022

Feb 14, 2023

BUY
$4.26 - $6.84 $34,693 - $55,704
8,144 Added 10.32%
87,084 $405,000
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $75,780 - $160,814
12,505 Added 18.82%
78,940 $478,000
Q2 2022

Aug 12, 2022

BUY
$8.35 - $21.89 $74,548 - $195,433
8,928 Added 15.53%
66,435 $694,000
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $288,522 - $470,693
11,266 Added 24.36%
57,507 $1.8 Million
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $7,801 - $11,112
397 Added 0.87%
46,241 $1.08 Million
Q2 2021

Aug 16, 2021

SELL
$17.48 - $25.46 $46,112 - $67,163
-2,638 Reduced 5.44%
45,844 $1.04 Million
Q1 2021

May 14, 2021

SELL
$18.08 - $28.8 $122,112 - $194,515
-6,754 Reduced 12.23%
48,482 $1.11 Million
Q4 2020

Mar 01, 2021

SELL
$11.7 - $23.41 $132,256 - $264,626
-11,304 Reduced 16.99%
55,236 $1.21 Million
Q3 2020

Nov 13, 2020

BUY
$11.21 - $13.82 $55,780 - $68,768
4,976 Added 8.08%
66,540 $781,000
Q2 2020

Aug 14, 2020

SELL
$9.8 - $12.77 $58,653 - $76,428
-5,985 Reduced 8.86%
61,564 $701,000
Q1 2020

May 15, 2020

BUY
$8.78 - $18.6 $2,932 - $6,212
334 Added 0.5%
67,549 $753,000
Q4 2019

Feb 14, 2020

BUY
$13.12 - $17.06 $186,317 - $242,269
14,201 Added 26.79%
67,215 $1.07 Million
Q3 2019

Nov 14, 2019

BUY
$12.75 - $19.01 $115,540 - $172,268
9,062 Added 20.62%
53,014 $727,000
Q2 2019

Aug 15, 2019

BUY
$17.0 - $21.88 $109,922 - $141,476
6,466 Added 17.25%
43,952 $0
Q1 2019

May 14, 2019

BUY
$15.53 - $22.15 $267,845 - $382,021
17,247 Added 85.22%
37,486 $0
Q4 2018

Feb 13, 2019

BUY
$14.06 - $22.57 $284,560 - $456,794
20,239 New
20,239 $337,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $257M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.